Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    Open Studies | "Polycystic Kidney Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Polycystic Kidney Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Early-Stage Polycystic Kidney Disease Biomarkers Repository Study
Condition: Polycystic Kidney Disease
Intervention:
2 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
3 Recruiting Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition: Polycystic Kidney Disease
Interventions: Dietary Supplement: Niacinamide;   Other: Placebo
4 Recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
5 Not yet recruiting A Randomised Feasibility Trial of High Water Intake in Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Dietary Supplement: High water intake;   Other: Ad libitum water intake
6 Recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
7 Recruiting Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Interventions: Drug: Pioglitazone;   Drug: Placebo
8 Not yet recruiting The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Device: Vessix
9 Recruiting Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Tolvaptan;   Drug: Matching Placebo
10 Recruiting Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Metformin;   Other: Placebo
11 Recruiting PKD Clinical and Translational Core Study
Condition: Polycystic Kidney Disease
Intervention:
12 Recruiting Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
Conditions: Polycystic Kidney, Type 1 Autosomal Dominant Disease;   Polycystic Kidney, Type 2 Autosomal Dominant Disease
Interventions: Drug: Sirolimus;   Drug: Placebo
13 Recruiting A Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Intervention: Drug: KD019 (tesevatinib)
14 Recruiting Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical Trial
Condition: Polycystic Kidney, Type 1 Autosomal Dominant Disease
Intervention: Procedure: Preimplantation Genetic Diagnosis
15 Recruiting Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
16 Recruiting Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Other: Blood Collection
17 Not yet recruiting Efficacy of Tolvaptan on ADPKD Patients
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tolvaptan
18 Recruiting A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
19 Recruiting The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
20 Recruiting Effect of the Aquaretic Tolvaptan on Nitric Oxide System
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.